Neurophet, the first company in Korea, selected by Roche Diagnostics for Startup Creasphere's APAC innovation program
- Written by PR Newswire
![]() |
- Aim to evaluate and explore the commercialization opportunities of an amyloid-positive prediction technology for Alzheimer's disease based on MRI analysis
SEOUL, South Korea, Sept. 5, 2023 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in the global startup innovation...















